Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCE-MRI Assessment of Bevacizumab +/- Interferon-alpha in Advanced Renal Cell Carcinoma
NCT00873236Phase 2Unknown
- Sponsor
- Mount Vernon Cancer Centre
- Start
- Apr 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in renal cell carcinoma (RCC), sponsored by Mount Vernon Cancer Centre. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00873236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00873236.